Hainan Huluwa Pharmaceutical Group Co., Ltd

Chine

Retour au propriétaire

1-10 de 10 pour Hainan Huluwa Pharmaceutical Group Co., Ltd Trier par
Recheche Texte
Affiner par
Type PI
        Brevet 8
        Marque 2
Date
2024 2
2022 6
2021 1
2020 1
Classe IPC
A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés 3
A61K 131/00 - Parties de plantes contenant des graines ou des semences, des noix ou des noisettes, des fruits ou des grains, ou obtenues à partir de ces éléments 2
A61K 9/16 - AgglomérésGranulésMicrobilles 2
A61P 1/14 - Eupeptiques, p. ex. acides, enzymes, orexigènes, antidyspeptiques, toniques, antiflatulants 2
A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire 2
Voir plus
Résultats pour

1.

HULUWA

      
Numéro d'application 1792977
Statut Enregistrée
Date de dépôt 2023-12-21
Date d'enregistrement 2023-12-21
Propriétaire Hainan Huluwa Pharmaceutical Group Co., Ltd. (Chine)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Medicines for human purposes; mineral dietary supplements; medicines made of chinese traditional medicinal herbs; powdered milk for babies; dietetic substances adapted for medical use; food for babies; nutritional supplements; vitamin preparations; probiotic preparations for medical use; medicated candies.

2.

HLSJ

      
Numéro d'application 1788941
Statut Enregistrée
Date de dépôt 2023-12-21
Date d'enregistrement 2023-12-21
Propriétaire Hainan Huluwa Pharmaceutical Group Co., Ltd. (Chine)
Classes de Nice  ? 05 - Produits pharmaceutiques, vétérinaires et hygièniques

Produits et services

Medicines for human purposes; mineral dietary supplements; medicines made of chinese traditional medicinal herbs; powdered milk for babies; dietetic substances adapted for medical use; food for babies; nutritional supplements; vitamin preparations; probiotic preparations for medical use; medicated candies; dietary fibre; plant extracts for pharmaceutical purposes; eye drops; medicinal drinks; pharmaceutical preparations for skin care.

3.

ARECA NUT EXTRACT CAPABLE OF IMPROVING GASTRIC MOTILITY, PREPARATION PROCESS THEREFOR, AND APPLICATION THEREOF

      
Numéro d'application CN2021079132
Numéro de publication 2022/178913
Statut Délivré - en vigueur
Date de dépôt 2021-03-04
Date de publication 2022-09-01
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wang, Jia
  • Li, Dang
  • Wu, Weizhen
  • Wu, Yuqiang

Abrégé

An areca nut extract capable of improving gastric motility, a preparation process therefor, and an application thereof. The preparation process comprises the following steps: taking fried areca nut traditional Chinese medicinal materials and crushing same; taking diethyl ether, ethanol, and chloroform according to a volume ratio of 1:0.2-0.3:0.03-0.05 as an extraction solvent; adding a carbonate buffer solution; shaking and extracting for 20-40 minutes; performing heat reflux extraction for 20-40 minutes; collecting an extracted solution; repeatedly performing reflux extraction for 2-3 times; combining all extracted solutions; adding a composite adsorbent which is prepared from chitosan, diatomite, and activated carbon; standing for 15-20 minutes; filtering and concentrating the filtrate at 60-70°C under reduced pressure to form a thick paste; and drying the thick paste to obtain the areca nut extract. The prepared areca nut extract not only obviously improves the transfer rates of arecoline, arecaidine, and areca polyphenol, but also effectively removes heavy metal such as lead, arsenic, and mercury, improves the activity and safety of the areca nut extract, can obviously decrease the residual rate of phenol red in the stomach of a mouse, has a good gastric emptying effect, and can be better applied to preparation of a medicine for improving gastric motility.

Classes IPC  ?

  • A61K 36/889 - Arecaceae, Palmae ou Palmaceae (famille du palmier), p. ex. dattier ou cocotier ou palmier nain
  • A61P 1/14 - Eupeptiques, p. ex. acides, enzymes, orexigènes, antidyspeptiques, toniques, antiflatulants
  • A61K 131/00 - Parties de plantes contenant des graines ou des semences, des noix ou des noisettes, des fruits ou des grains, ou obtenues à partir de ces éléments

4.

METHOD FOR PREPARING PHARBITIDIS SEMEN EXTRACT

      
Numéro d'application CN2021085215
Numéro de publication 2022/178953
Statut Délivré - en vigueur
Date de dépôt 2021-04-02
Date de publication 2022-09-01
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wang, Jia
  • Li, Dang
  • Wu, Weizhen
  • Wu, Yuqiang

Abrégé

Provided is a method for preparing a Pharbitidis semen extract. The method comprises the following steps: S1, crushing a traditional Chinese medicinal material, Pharbitidis semen, and performing sieving; S2, soaking the crushed Pharbitidis semen in a sodium bicarbonate solution, and then concentrating the mixture to obtain Pharbitidis semen powder; S3, soaking the Pharbitidis semen powder obtained in step S2 in an ethanol solution; S4, concentrating the soaked solution under reduced pressure to obtain soaked Pharbitidis semen powder; S5, adding the soaked Pharbitidis semen powder to ethyl acetate, and performing microwave extraction to obtain a first extracted solution and a first solution residue; S6, adding ethyl acetate to the first solution residue, and performing microwave extraction to obtain a second extracted solution and a second solution residue; S7, mixing the first extracted solution and the second extracted solution, filtering the mixture, concentrating the filtrate under reduced pressure, and recovering a solvent from the extracted solution to obtain a paste; and S8, adding deionized water for dissolving, slowly adding the obtained solution to a macroporous resin for purification, leaving to stand for 1-2 h, performing gradient elution with an aqueous ethanol solution, then concentrating same under reduced pressure, and drying same in vacuo to obtain the Pharbitidis semen extract.

Classes IPC  ?

  • A61K 36/39 - Convolvulaceae (famille de la belle-de-jour), p. ex. liseron
  • A61P 1/14 - Eupeptiques, p. ex. acides, enzymes, orexigènes, antidyspeptiques, toniques, antiflatulants
  • A61K 131/00 - Parties de plantes contenant des graines ou des semences, des noix ou des noisettes, des fruits ou des grains, ou obtenues à partir de ces éléments

5.

SHANZHUANG LIPID-LOWERING MICROPELLET AND PREPARATION METHOD THEREFOR

      
Numéro d'application CN2021077618
Numéro de publication 2022/160397
Statut Délivré - en vigueur
Date de dépôt 2021-02-24
Date de publication 2022-08-04
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wang, Jia
  • Li, Dang

Abrégé

A Shanzhuang lipid-lowering micropellet and a preparation method therefor. The micropellet is prepared from the following raw materials in parts by weight: 1240 parts of semen cassiae, 620 parts of hawthorn, 420 parts of lotus leaves, 150-320 parts of dextrin, 20-36 parts of sucrose, 15-32 parts of konjac glucomannan, and 18-25 parts of hydroxypropylmethyl cellulose. The prepared Shanzhuang lipid-lowering micropellet has a relatively high content of active ingredients, i.e. chrysophanol and aurantio-obtusin. The active ingredient of lotus leaves is nuciferine, which is an alkaloid, and lotus leaves are extracted separately from hawthorn so as to avoid possible reactions with an acid, thereby increasing active ingredients of the micropellet. Hawthorn is extracted with an ionic liquid, so that the flavonoid substances and the like in hawthorn can be completely extracted. The use of a micropellet dosage form can shorten the disintegration time of a drug in the human body, thereby improving the utilization rate of the drug.

Classes IPC  ?

  • A61K 36/734 - Crataegus (aubépine)
  • A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
  • A61P 3/06 - Antihyperlipémiants
  • A61K 9/50 - Microcapsules
  • A61K 47/38 - CelluloseSes dérivés
  • A61K 36/482 - Cassia, p. ex. canéficier
  • A61K 36/62 - Nymphaeaceae (famille du nénuphar)

6.

COLD AND COUGH GRANULES AND PREPARATION METHOD THEREFOR

      
Numéro d'application CN2021072048
Numéro de publication 2022/134244
Statut Délivré - en vigueur
Date de dépôt 2021-01-15
Date de publication 2022-06-30
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wu, Yuqiang
  • Zheng, Guoju
  • Wang, Jia
  • Li, Dang

Abrégé

Cold and cough granules and a preparation method therefor, the method comprising the following steps: taking 15-25% of trichosanthes root according to a prescription, crushing, passing same through a sieve of 70-90 meshes to obtain a fine powder of trichosanthes root; taking the remaining amount in the prescription of trichosanthes root with honeysuckle, loquat leaves, stemona root, and balloon flower root, crushing, and passing same through a sieve of 30-50 meshes, adding an ethanol solution for extraction, then filtering, and saving the resulting medicinal residue for later use, recovering ethanol from the filtrate until no smell of alcohol is present so as to obtain an extraction solution A; taking the medicinal residue, adding a sodium hydroxide solution to same for ultrasonic extraction, filtering, and adjusting the pH value of the filtrate to neutral by using a hydrochloric acid solution, so as to obtain an extraction solution B; combining the extraction solution A with the extraction solution B, concentrating same to obtain a clear paste, adding the fine powder of trichosanthes root, sucrose and dextrin to same, and mixing, granulating and drying to obtain granules; taking eucalyptus oil, encapsulating with hydroxypropyl-β-cyclodextrin to obtain an encapsulated matter; and taking the granules and the encapsulated matter, adding talc to same, and mixing well to prepare the cold and cough granules.

Classes IPC  ?

7.

HEAT-CLEARING AND EXTERIOR SYNDROME-RELIEVING TRADITIONAL CHINESE MEDICINE COMPOSITION AND PREPARATION METHOD THEREFOR

      
Numéro d'application CN2021072050
Numéro de publication 2022/134245
Statut Délivré - en vigueur
Date de dépôt 2021-01-15
Date de publication 2022-06-30
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wu, Yuqiang
  • Zheng, Guoju
  • Wang, Jia
  • Li, Dang

Abrégé

A heat-clearing and exterior syndrome-relieving traditional Chinese medicine composition and a preparation method therefor. The preparation method comprises the following steps: extracting volatile oils from Herba Pogostemonis and Herba Menthae to obtain the volatile oils, and retaining a distilled aqueous solution for use; soaking Flos Chrysanthemi and Fructus Forsythiae in an aqueous ethanol solution, performing ultrasound extraction and filtration, retaining the herb residue for use, and recovering ethanol from the filtrate to obtain a clear paste; taking Folium Isatidis, Radix Rehmanniae, Radix Cynanchi Atrati, Cortex Lycii, gypsum accounting for 75-85% of the amount thereof, and the herb residue, adding an aqueous ethanol solution for heat reflux extraction, mixing the extract solutions and filtering the mixture, after recovering ethanol from the filtrate, mixing the filtrate with the aqueous solution and the clear paste, and performing concentration to form a thick paste; taking the volatile oils to prepare a volatile oil inclusion compound; taking the remaining amount of gypsum and Radix Isatidis and crushing same into fine powder to obtain medicinal material fine powder, and sterilizing the medicinal material fine powder for later use; mixing the medicinal material fine powder with auxiliary materials, adding the thick paste, mixing uniformly, preparing particles, drying same, then adding the volatile oil inclusion compound, and mixing uniformly to obtain the composition. The present invention improves the contents of phillyrin and total flavonoids of Flos Chrysanthemi in the product, thereby improving the efficacy of the product.

Classes IPC  ?

  • A61K 36/815 - Lycium (lyciet)
  • A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
  • A61K 9/16 - AgglomérésGranulésMicrobilles
  • A61K 47/40 - CyclodextrinesLeurs dérivés
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
  • A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus

8.

TRADITIONAL CHINESE MEDICINE COMPOSITION AND TRADITIONAL CHINESE MEDICINE COMPOSITION PREPARATION FOR TREATING INFLUENZA, AND PREPARATION METHODS THEREFOR AND USE THEREOF

      
Numéro d'application CN2020142176
Numéro de publication 2022/041629
Statut Délivré - en vigueur
Date de dépôt 2020-12-31
Date de publication 2022-03-03
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wu, Yuqiang
  • Zheng, Guoju

Abrégé

A traditional Chinese medicine composition and a traditional Chinese medicine composition preparation for treating an influenza, particularly an infantile influenza, and preparation methods therefor and a use thereof. The traditional Chinese medicine composition comprises the following active pharmaceutical ingredients in parts by weight: 50-200 parts of Nauclea officinalis, 100-260 parts of gypsum, 50-150 parts of Scutellaria baicalensis, 50-200 parts of Artemisia carvifolia, 50-150 parts of honeysuckle, 50-150 parts of reed rhizome, 50-150 parts of rhizoma anemarrhenae, 30-100 parts of Radix platycodonis, and 20-60 parts of licorice.

Classes IPC  ?

  • A61K 36/899 - Poaceae ou Gramineae (famille des céréales), p. ex. bambou, blé ou canne à sucre
  • A61K 36/8964 - Anemarrhena
  • A61K 36/74 - Rubiaceae (famille de la garance)
  • A61K 36/539 - Scutellaria (calotte)
  • A61K 36/484 - Glycyrrhiza (réglisse)
  • A61K 36/35 - Caprifoliaceae (famille du chèvrefeuille)
  • A61K 36/34 - Campanulaceae (famille de la campanule)
  • A61K 36/282 - Artemisia, p. ex. armoise
  • A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
  • A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
  • A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire

9.

PREPARATION METHOD FOR FIRE-PURGING TABLET

      
Numéro d'application CN2020142179
Numéro de publication 2021/253803
Statut Délivré - en vigueur
Date de dépôt 2020-12-31
Date de publication 2021-12-23
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD. (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Wang, Jia

Abrégé

A preparation method for a fire-purging tablet, comprising: S1, adding water to the isatis leaf, decocting, filtering, and concentrating to a thick paste; adding the thick paste to fine powder which is crushed from root and rhizome of sorrel rhubarb and gypsum, and an adjuvant, and uniformly mixing to prepare granules; S2, the preparation of a menthol inclusion compound, comprising: (1) dissolving menthol into ethanol to obtain a menthol solution; (2) adding ß-cyclodextrin to water at 45-65ºC and grinding for 10-45 minutes using a colloid mill to obtain a cyclodextrin solution; (3) mixing the menthol solution with the ß-cyclodextrin solution and grounding into an emulsion using a colloid mill; and S3, uniformly mixing the granules obtained in the step S1 with the emulsion obtained in the step S2, drying, pressing into tablets, and coating to prepare the fire-purging tablet. The tablet prepared by the method is high in menthol inclusion rate, stable in content, short in tablet disintegration time limit, better in formability, and good in taste.

Classes IPC  ?

  • A61K 36/855 - Clerodendrum, p. ex. clerodendrum cyrtophyllum
  • A61K 36/708 - Rheum (rhubarbe)
  • A61K 36/315 - Isatis, p. ex. indigo
  • A61K 36/19 - Acanthaceae (famille de l'acanthe)
  • A61K 47/69 - Préparations médicinales caractérisées par les ingrédients non actifs utilisés, p. ex. les supports ou les additifs inertesAgents de ciblage ou de modification chimiquement liés à l’ingrédient actif l’ingrédient non actif étant chimiquement lié à l’ingrédient actif, p. ex. conjugués polymère-médicament le conjugué étant caractérisé par sa forme physique ou sa forme galénique, p. ex. émulsion, particule, complexe d’inclusion, stent ou kit
  • A61K 31/045 - Composés hydroxylés, p. ex. alcoolsLeurs sels, p. ex. alcoolates
  • A61K 33/06 - Aluminium, calcium ou magnésiumLeurs composés
  • A61K 9/28 - DragéesPilules ou comprimés avec revêtements
  • A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

10.

METHOD FOR DETECTING INFANTILE ACCUMULATION-ELIMINATING GRANULES

      
Numéro d'application CN2019122864
Numéro de publication 2020/140670
Statut Délivré - en vigueur
Date de dépôt 2019-12-04
Date de publication 2020-07-09
Propriétaire HAINAN HULUWA PHARMACEUTICAL GROUP CO., LTD (Chine)
Inventeur(s)
  • Liu, Jingping
  • Liu, Quanguo
  • Chen, Keling
  • Lin, Guo

Abrégé

Disclosed is a quality control method for infantile accumulation-eliminating granules. The method comprises: using thin-layer chromatography to perform qualitative identification on parched Crataegi fructus and Pharbitidis semen in infantile accumulation-eliminating granules; using high-performance liquid chromatography to determine the content of an activation component, arecoline, in the infantile accumulation-eliminating granules to carry out quantitative control; and using a potentiometric titration method to determine the content of organic acids in the infantile accumulation-eliminating granules. The method of the present invention is simple, has a good degree of separation, strong specificity and good reproducibility, thereby effectively guaranteeing the quality and curative effect of the infantile accumulation-eliminating granules, and having very strong practicality.

Classes IPC  ?

  • G01N 30/90 - Chromatographie sur plaque, p. ex. chromatographie en couche mince ou chromatographie sur papier
  • G01N 30/94 - Développement
  • G01N 30/95 - Détecteurs spécialement adaptés à cet effetAnalyse des signaux
  • G01N 30/02 - Chromatographie sur colonne
  • G01N 30/06 - Préparation
  • G01N 30/74 - Détecteurs optiques
  • G01N 31/16 - Utilisation du titrage